tablet-yellow

Gentamicin (Garamycin, Gentak)

Anesthesia Implications

Updated On: July 23, 2026

Classification:
Aminoglycoside antibiotic
Therapeutic Effects:
Bactericidal, aerobic gram-negative coverage, surgical prophylaxis (often combined with an agent for gram-positive/anaerobic cover)
Time to Onset:

Rapid (concentration-dependent killing)

Time to Peak Effects:

30-60 min after infusion

Duration:

Post-antibiotic effect extends coverage; dosing interval 24 h for single-dose regimens

Primary Considerations:

NMB potentiation - Aminoglycosides inhibit prejunctional acetylcholine release and reduce postjunctional sensitivity; they prolong non-depolarizing NMB and can cause recurarization. Monitor TOF and titrate reversal carefully.

Prophylaxis timing/dosing - Single preoperative dose within 60 minutes of incision; dose on adjusted body weight in obesity (IBW + 0.4 x (TBW - IBW)) to avoid overdosing.

Nephro/ototoxicity - Minimize concurrent nephrotoxins (NSAIDs, contrast, vancomycin, loop diuretics); maintain intravascular volume.

Drug Interactions - Additive with non-depolarizing NMBs, other nephrotoxins, and ototoxins (loop diuretics); calcium may partially reverse aminoglycoside-induced block.

Pediatric Implications - Weight-based (2.5 mg/kg); neonates need extended dosing intervals due to immature renal clearance.

Obstetric Implications - Category D; crosses the placenta with a risk of fetal ototoxicity. Reserve for serious infections when benefit outweighs risk. Minimal transfer into breast milk.

Contraindications:

Relative:

Significant renal impairment

Myasthenia gravis

Pre-existing hearing/vestibular loss

Caution:

Concurrent nephrotoxins or NMBs

Hypovolemia

IV push dose:

Surgical prophylaxis: 5 mg/kg IV single preoperative dose on adjusted body weight (adult); 2.5 mg/kg (pediatric). Infuse over 30-60 min.

Method of Action:

Binds the bacterial 30S ribosomal subunit, causing misreading of mRNA and irreversible inhibition of protein synthesis; concentration-dependent bactericidal activity.

Metabolism:

None (not metabolized)

Elimination:

Renal

Additional Notes:

Infuse over 30-60 min (never IV push). Extended-interval (once-daily) dosing preferred; monitor levels and renal function with repeated dosing.


Suggested Reading

Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health-Syst Pharm. 2013;70(3):195-283.link
Chaves BJ, Tadi P. Gentamicin. StatPearls. Updated 2023.link
Naguib M, et al. Advances in neuromuscular pharmacology. Anesthesiology. 2022. (aminoglycoside-NMB interaction)link